SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001140361-22-036080
Filing Date
2022-10-04
Accepted
2022-10-04 16:30:28
Documents
4
Group Members
ACHILLE G. SEVERGNINIAVARA MANAGEMENT LTDGG 1978 SICAF SIF S.A.GG1978 SICAF SIF S.A. - GG STRATEGICGISEV TRUSTEES LTDMGG STRATEGIC SICAF SIF S.A.MGG STRATEGIC SICAF SIF S.A. - MGG STRATEGICSKYELINE MANAGEMENT LTD

Document Format Files

Seq Description Document Type Size
1 SC 13D/A brhc10042533_sc13da.htm SC 13D/A 316467
2 EXHIBIT F brhc10042533_ex99-f.htm EX-99.F 33782
3 EXHIBIT G brhc10042533_ex99-g.htm EX-99.G 33549
4 EXHIBIT H brhc10042533_ex99-h.htm EX-99.H 4544
  Complete submission text file 0001140361-22-036080.txt   389937
Mailing Address 110 EAST 59TH STREET NEW YORK NY 10022
Business Address 110 EAST 59TH STREET NEW YORK NY 10022 (212) 883-0200
Royalty Pharma plc (Subject) CIK: 0001802768 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-91540 | Film No.: 221292113
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GISEV FAMILY OFFICE SA CONTRADA DI SASSELLO 2 LUGANO V8 6900
Business Address
Giuliani Mario Germano (Filed by) CIK: 0001814882 (see all company filings)

Type: SC 13D/A